Neuland Laboratories has announced that its management will engage with analysts and institutional investors through a non-deal roadshow scheduled for June 11, 2026. The meeting, organized by Goldman Sachs, will be held in Hyderabad and will serve as a platform for the company to present its business outlook and operational performance to potential investors.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Sarada Bhamidipati, Company Secretary of Neuland Laboratories Limited, confirmed the schedule in the filing submitted on June 5, 2026.

The event will feature both group meetings and one-on-one interactions, allowing for detailed discussions regarding the company's financial health and strategic initiatives. The schedule and participant list remain subject to change based on exigencies from either the participants or the company.

Meeting Schedule

Neuland Laboratories Limited has informed the stock exchanges that its management will participate in the Nuvama India Conference 2026 (UK Edition) scheduled for June 8 and 9, 2026. The disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This engagement allows the company to present its outlook directly to analysts and institutional investors.

The event will take place in London, United Kingdom. The management is scheduled to conduct both group meetings and one-on-one sessions with attendees. The schedule and participant list remain subject to change due to exigencies on the part of the participants or the company.

The following table outlines the details of the participation:

Sarada Bhamidipati, Company Secretary of neuland laboratories , signed the intimation on June 3, 2026. The filing was submitted to BSE Limited and The National Stock Exchange of India Ltd for their information and records.